Bolt Biotherapeutics, Inc.

BOLT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$7,205$10,810$9,244$27,383
Short-Term Investments$40,118$91,379$159,644$158,836
Receivables$1,165$0$0$200
Inventory$0$0$0$0
Other Curr. Assets$2,326$3,519$3,858$2,741
Total Curr. Assets$50,814$105,708$172,746$189,160
Property Plant & Equip (Net)$24,895$24,077$28,525$30,603
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$22,880$26,413$23,943$86,913
Tax Assets$0$0$0$0
Other NC Assets$1,043$3,586$2,593$1,042
Total NC Assets$48,818$54,076$55,061$118,558
Other Assets$0$0$0$0
Total Assets$99,632$159,784$227,807$307,718
Liabilities
Payables$1,507$2,987$3,594$3,574
Short-Term Debt$2,251$2,782$2,391$2,501
Tax Payable$0$0$0$0
Deferred Revenue$3,015$2,201$1,993$2,869
Other Curr. Liab.$9,083$12,486$15,140$12,384
Total Curr. Liab.$15,856$20,456$23,118$21,328
LT Debt$22,958$17,437$20,220$21,854
Deferred Rev, NC$3,620$9,107$12,921$14,207
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$43$42$210
Total NC Liab.$26,578$26,587$33,183$36,271
Other Liabilities$0$0$0$0
Cap. Leases$25,209$20,219$22,611$21,854
Total Liabilities$42,434$47,043$56,301$57,599
Equity
Pref Stock$0$0$0$0
Common Stock$0$1$0$0
Retained Earnings-$427,403-$364,285-$295,088-$206,990
AOCI$97$37-$919-$321
Other Equity$484,504$476,988$467,513$457,430
Total Equity$57,198$112,741$171,506$250,119
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$99,632$159,784$227,807$307,718
Net Debt$18,004$9,409$13,367-$3,028